Skip to main content
. Author manuscript; available in PMC: 2015 May 15.
Published in final edited form as: Exp Cell Res. 2014 Feb 8;324(1):40–53. doi: 10.1016/j.yexcr.2014.01.024

Figure 6. Effect of the combinatorial compounds on the expression of HDAC1, DNMT1 and survivin in RKO, HCT-116 and HT-29 colorectal cancer cells.

Figure 6

Figure 6

The combination treatment was significantly effective in down-regulating the expression of HDAC1, DNMT1 and survivin in all the three colon cancer cells tested (A, B, C, respectively). The western blot was performed in triplicate and densitometric analysis of the bands was performed. The data represent values normalized to β-actin and then computed as relative to the control. A representative western is shown as an inset in the graph for each protein type tested. C = control; E = EGCG; N = NaB and E + N = EGCG + NaB.